May 14, 2014 Cellectar Biosciences Reports First Quarter 2014 Financial Results and Recent Highlights Learn More
May 12, 2014 Cellectar Biosciences to Host Conference Call on May 14th to Discuss First Quarter 2014 Results and Provide Quarterly Update on Development Progress Learn More
May 5, 2014 Cellectar Biosciences Announces Receipt of Orphan Designation of I-124-CLR1404 as Diagnostic for the Management of Glioma from U.S. Food and Drug Administration Learn More
Apr 2, 2014 Dr. Simon Pedder Becomes President and Chief Executive Officer of Cellectar Biosciences Learn More